Tough Tech Today with Meyen and Miller

Exposing cancer with bioengineering, featuring Cyriac Roeding of Earli

March 23, 2021 Jonathan 'jmill' Miller, Forrest Meyen, and Cyriac Roeding Season 1 Episode 16
Tough Tech Today with Meyen and Miller
Exposing cancer with bioengineering, featuring Cyriac Roeding of Earli
Chapters
Tough Tech Today with Meyen and Miller
Exposing cancer with bioengineering, featuring Cyriac Roeding of Earli
Mar 23, 2021 Season 1 Episode 16
Jonathan 'jmill' Miller, Forrest Meyen, and Cyriac Roeding

In one sentence:

We can make cancer cells tell us exactly where they are.
—————

Overview:

Consumer internet entrepreneurs lack many of the skills for the life sciences revolution – or do they? Cyriac Roeding, CEO and co-founder of Earli, shows us what his team of bioengineers are accomplishing by applying fast-learning software development discipline to hard life science problems. Earli’s mouse and canine models are producing exciting results inducing cancer cells to expose their locations, enabling precision medicine to pinpoint malignant from benign many months earlier than state-of-the-art techniques. “I love the idea of having multiple shots on goal… rather than spending a billion dollars on small molecule development,” says Cyriac.

As expeditiously as it has progressed, the Earli story is not without its difficult periods, including the death of a gifted co-founder. “First, I cried... I [had become] very close to him. As brilliant a scientist as he was, he was an even more wonderful human being. I loved this man,” shares Cyriac. “Our team rallied behind the whole situation,” and we learn how Cyriac, his co-founder, and the Earli team reinforced their commitment to save lives as quickly as they can.

 —————

Show Notes:


Show Notes

In one sentence:

We can make cancer cells tell us exactly where they are.
—————

Overview:

Consumer internet entrepreneurs lack many of the skills for the life sciences revolution – or do they? Cyriac Roeding, CEO and co-founder of Earli, shows us what his team of bioengineers are accomplishing by applying fast-learning software development discipline to hard life science problems. Earli’s mouse and canine models are producing exciting results inducing cancer cells to expose their locations, enabling precision medicine to pinpoint malignant from benign many months earlier than state-of-the-art techniques. “I love the idea of having multiple shots on goal… rather than spending a billion dollars on small molecule development,” says Cyriac.

As expeditiously as it has progressed, the Earli story is not without its difficult periods, including the death of a gifted co-founder. “First, I cried... I [had become] very close to him. As brilliant a scientist as he was, he was an even more wonderful human being. I loved this man,” shares Cyriac. “Our team rallied behind the whole situation,” and we learn how Cyriac, his co-founder, and the Earli team reinforced their commitment to save lives as quickly as they can.

 —————

Show Notes: